1. Home
  2. UTHR vs GLPI Comparison

UTHR vs GLPI Comparison

Compare UTHR & GLPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • GLPI
  • Stock Information
  • Founded
  • UTHR 1996
  • GLPI 2013
  • Country
  • UTHR United States
  • GLPI United States
  • Employees
  • UTHR N/A
  • GLPI N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • GLPI Real Estate Investment Trusts
  • Sector
  • UTHR Health Care
  • GLPI Real Estate
  • Exchange
  • UTHR Nasdaq
  • GLPI Nasdaq
  • Market Cap
  • UTHR 13.4B
  • GLPI 13.0B
  • IPO Year
  • UTHR 1999
  • GLPI N/A
  • Fundamental
  • Price
  • UTHR $294.28
  • GLPI $46.15
  • Analyst Decision
  • UTHR Buy
  • GLPI Buy
  • Analyst Count
  • UTHR 13
  • GLPI 16
  • Target Price
  • UTHR $379.69
  • GLPI $52.58
  • AVG Volume (30 Days)
  • UTHR 547.4K
  • GLPI 1.9M
  • Earning Date
  • UTHR 07-30-2025
  • GLPI 07-24-2025
  • Dividend Yield
  • UTHR N/A
  • GLPI 6.76%
  • EPS Growth
  • UTHR 17.94
  • GLPI N/A
  • EPS
  • UTHR 25.63
  • GLPI 2.61
  • Revenue
  • UTHR $3,077,800,000.00
  • GLPI $1,565,067,000.00
  • Revenue This Year
  • UTHR $14.37
  • GLPI $6.17
  • Revenue Next Year
  • UTHR $6.59
  • GLPI $3.51
  • P/E Ratio
  • UTHR $11.48
  • GLPI $17.71
  • Revenue Growth
  • UTHR 17.62
  • GLPI 5.38
  • 52 Week Low
  • UTHR $266.98
  • GLPI $44.48
  • 52 Week High
  • UTHR $417.82
  • GLPI $52.60
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 49.57
  • GLPI 44.26
  • Support Level
  • UTHR $272.12
  • GLPI $45.30
  • Resistance Level
  • UTHR $307.71
  • GLPI $46.78
  • Average True Range (ATR)
  • UTHR 8.47
  • GLPI 0.81
  • MACD
  • UTHR -1.25
  • GLPI -0.19
  • Stochastic Oscillator
  • UTHR 62.26
  • GLPI 29.01

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About GLPI Gaming and Leisure Properties Inc.

Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.

Share on Social Networks: